INNATE PHARMA SA-SPONS ADR
IPHANASDAQ🏆 #3838 by market capEarnings Nov 5US Equity
$1.66▲ $0.06 (+3.75%)
LiveTrack IPHA
Get earnings, price moves & breaking news on Telegram
24h▲ 3.8%
7d▼ 7.8%
14d▼ 18.2%
30d▼ 24.9%
ytd▼ 6.7%
1y▼ 12.2%
🏦Market Cap
$156M
Small Cap
📈Revenue Growth (YoY)
-77.9%
Declining
📊Gross Margin
1770.3%
High
💵FCF Margin
-4108.2%
Thin
⚖️P/S Ratio
126.3x
Expensive
Otter Score
60
Fair
INNATE PHARMA SA-SPONS ADR
IPHAAnalyst Ratings
Price
$1.66
Total
6
Raised
0
Lowered
1
Avg PT
$6.67
H / L
$9 / $4
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
BTIG | Reiterated | Buy | 2026-09-17 | $9.00 | +442.20% |
HC Wainwright & Co. | Reiterated | Buy | 2026-08-10 | — | — |
Leerink Partners | Downgraded | Outperform → Market Perform | 2025-09-18 | $4.00 | +141.00% |
SVB Leerink | Reiterated | Outperform | 2022-11-15 | — | — |
Citigroup | Reiterated | Buy | 2022-09-16 | — | — |
Goldman Sachs | Reiterated | Neutral | 2020-11-24 | — | — |
Institution
BTIG
Reiterated · Buy · 2026-09-17
$9.00
+442.20%
HC Wainwright & Co.
Reiterated · Buy · 2026-08-10
—
—
Leerink Partners
Downgraded · Outperform → Market Perform · 2025-09-18
$4.00
+141.00%
SVB Leerink
Reiterated · Outperform · 2022-11-15
—
—
Citigroup
Reiterated · Buy · 2022-09-16
—
—
Goldman Sachs
Reiterated · Neutral · 2020-11-24
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space